TGFBR2 and central nervous system cancer: Ye et al. demonstrated that GAMs expressively augmented the invasive ability of glioma stem-like cells (GSLCs) via paracrine generation of TGF-β1 as well as the TGF-β1-TGFBR2 signaling pathway (Figure 4) [5].